These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 3954371

  • 21. Pharmacokinetics of recombinant interferon-alpha 2 following intralesional administration in malignant glioma patients.
    Maleci A, Antonelli G, Guidetti B, Dianzani F.
    J Interferon Res; 1987 Feb; 7(1):107-9. PubMed ID: 3585078
    [Abstract] [Full Text] [Related]

  • 22. Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain.
    Yagi K, Hayashi Y, Ishida N, Ohbayashi M, Ohishi N, Mizuno M, Yoshida J.
    Biochem Mol Biol Int; 1994 Jan; 32(1):167-71. PubMed ID: 8012282
    [Abstract] [Full Text] [Related]

  • 23. [Randomized study of initial treatment with radiation.MCNU or radiation.MCNU.interferon-beta for malignant glioma. Hiroshima Brain Tumor Study Group].
    Kiya K, Uozumi T, Kurisu K, Inagawa T, Ohta M, Kajikawa H, Kawashima K, Kitaoka T, Goishi A, Kodama Y.
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):221-6. PubMed ID: 2405777
    [Abstract] [Full Text] [Related]

  • 24. [Interferon therapy for primary brain tumors (Part II). DNA analysis and mean survival time].
    Nakagawa Y.
    Neurol Med Chir (Tokyo); 1984 Feb; 24(2):90-6. PubMed ID: 6205293
    [No Abstract] [Full Text] [Related]

  • 25. [The effectiveness of interferon-beta against glioma cells and its augmentation of growth inhibitory effect by transfection of its gene].
    Wakabayashi T, Mizuno M, Yoshida J.
    Hum Cell; 1995 Sep; 8(3):95-8. PubMed ID: 8652452
    [Abstract] [Full Text] [Related]

  • 26. Multimodality treatment of malignant gliomas. Comparison of several adjuvant approaches.
    Jellinger K, Volc D, Grisold W, Podreka I, Böck F, Schuster H, Alth G, Kogelnik HD.
    Zentralbl Neurochir; 1981 Sep; 42(2-3):99-119. PubMed ID: 6267846
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Local administration of interferon for malignant brain tumors.
    Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T.
    Cancer Treat Rep; 1983 Sep; 67(9):833-5. PubMed ID: 6688376
    [Abstract] [Full Text] [Related]

  • 33. Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas.
    Mahaley MS, Urso MB, Whaley RA, Blue M, Williams TE, Guaspari A, Selker RG.
    J Neurosurg; 1985 Nov; 63(5):719-25. PubMed ID: 2414420
    [Abstract] [Full Text] [Related]

  • 34. [Effect of human fibroblast interferon on malignant brain tumors].
    Nakamura O, Teramoto A, Yamamoto H, Ochiai C, Takakura K, Maruo K, Ueyama Y, Shimamura K.
    No To Shinkei; 1983 Sep; 35(9):905-11. PubMed ID: 6651989
    [Abstract] [Full Text] [Related]

  • 35. Status spongiosus in the course of treatment of malignant gliomas.
    Poisson M, Hauw JJ, Mashaly R, Duyckaerts C, Escourolle R.
    J Neurooncol; 1983 Sep; 1(1):29-37. PubMed ID: 6678304
    [Abstract] [Full Text] [Related]

  • 36. [Antiproliferative activities of interferon-alpha].
    Ishii K, Yoshida H, Yanagihara Y, Kiyonaga J, Shirahama T.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1983-9. PubMed ID: 4051515
    [Abstract] [Full Text] [Related]

  • 37. [Post-mortem observation of glioma and/or brain tissue compared to C-T scan findings after irradiation].
    Nakamura N, Kojima H, Nagashima K, Aida T, Kaneko S, Kitaoka K, Abe H.
    Gan No Rinsho; 1989 Sep; 35(11):1313-23. PubMed ID: 2810775
    [Abstract] [Full Text] [Related]

  • 38. High concentration of locally administered human fibroblast interferon in a glioblastoma multiforme. Discrepancy between clinical response and sensitivity of the tumor cells to the interferon in vitro.
    Fukui M, Sawa H, Takeshita I, Kitamura K, Satoh Y, Kasama K.
    Fukuoka Igaku Zasshi; 1986 Feb; 77(2):135-43. PubMed ID: 3011624
    [No Abstract] [Full Text] [Related]

  • 39. [Effect of interferon on malignant brain tumor].
    Wakabayashi T, Yoshida J, Kobayashi T, Kageyama N, Kanzaki M.
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1400-6. PubMed ID: 7184455
    [Abstract] [Full Text] [Related]

  • 40. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer.
    Ehtesham M, Samoto K, Kabos P, Acosta FL, Gutierrez MA, Black KL, Yu JS.
    Cancer Gene Ther; 2002 Nov; 9(11):925-34. PubMed ID: 12386831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.